With an objective of not giving any such scope for price escalation as Martin Shkreli did for Daraprim generic drug, US Food and Drug Administration (US FDA) has turned very cautious on approvals to generic drugs. US FDA is now reviewing new applications for generic drugs, while ensuring no such lapses of price escalation.
patent-expired
Breaking News
Subscribe to VCpost newsletter
Most Popular
- 940,000 Taxpayers May Receive Extra $932 Tax Refunds From IRS; Here's Why!
- China Hits 2 U.S. Defense Companies With Sanctions For Selling Military Weapons to Taiwan
- American Airlines Pilots Union Issues Urgent Safety Alert Over Maintenance Issues
- Innocent Female Uber Driver, 61, Shot Dead by 81-Year-Old Ohio Man Who Was Targeted by Scammers
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- Proposed Chinese Train Station Garners Attention Online as It Looks Like Sanitary Pad
- Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight
- Verizon $100 Million Settlement: How to Get Free 1-Month Home Internet Today?
